Alterations of lipoma HMGIC fusion partner (LHFPL3) were found to be more frequent in grade IV GBM, the survival rate of patients with mutations of LHFPL3 was significantly worse than the survival of patients without these alterations [12]. This evidence concerns the gene LHFPL3 and glioblastoma.